Trademark Overview
On Tuesday, May 13, 2025, a trademark application was filed for NEVIA with the United States Patent and Trademark Office. The USPTO has given the NEVIA trademark a serial number of 99183535. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 13, 2025. This trademark is owned by Enteronova Medical Technologies Inc.. The NEVIA trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Downloadable mobile application software for providing and optimizing neuromodulation therapy for gut health; Software for managing gastrointestinal and inflammatory conditions through AI-guided transcutaneous cervical vagus nerve stimulation (tcVNS) and transcutaneous auricular vagus nerve stimulation (taVNS); Software for providing and tracking brain-gut axis treatment sessions, providing personalized gut health recommendations, monitoring progress, and interfacing with wearable medical devices.
Providing digital health services in the field of gastroenterology, namely, personalized therapeutic support and remote monitoring for inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) through AI-guided neuromodulation therapy; Medical consultation and monitoring services using transcutaneous cervical and auricular vagus nerve stimulation delivered via wearable devices and mobile applications; Health services integrating bioelectronic therapy, symptom tracking, and real-time treatment adjustment to support immune modulation and inflammation reduction.
Non-invasive wearable medical devices for therapeutic neuromodulation, namely, devices that apply simultaneous transcutaneous cervical vagus nerve stimulation (tcVNS) and transcutaneous auricular vagus nerve stimulation (taVNS) for the treatment of inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Crohn’s Disease, and ulcerative colitis; Medical apparatus featuring dual-modality vagus nerve stimulation and AI-powered sensor feedback for modulating immune function and reducing gut inflammation.
